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To develop an approach to predicting adverse events
after percutaneous transluminal coronary angioplasty
(PTCA), 50 patients had thallium-201 exercise testing
within I month after successful single vessel coronary
angioplasty and werefollowed up for a meanof 18months.
Adverse events were: I) clinical events consisting of re-
current angina (17 patients) and myocardial infarction
(1 patient); 2) treatment events consisting of repeat coro-
nary angioplasty (10 patients) and coronary bypass sur-
gery (1 patient); and 3) restenosis, defined as a >30%
increase in luminal stenosis (IS of 38 recatheterized pa-
tients). There were no deaths. Of the clinical, exercise,
angiographic and thallium scan variables analyzed by
stepwise logistic regression, postangioplasty gradient >20
mm Hg predicted clinical events and treatment events,
and the number of segments with slower thallium clear-
ance predicted clinical events, treatment events and re-
Percutaneous transluminal coronary angioplasty (PTCA) has
been shown to be an effective technique for reducing coro-
nary stenosis and reestablishing myocardial blood flow.
However, there is a definite incidence of restenosis, recur-
rent angina and infarction. Any approach that would identify
a subset of coronary angioplasty patients at increased risk
would have important clinical value. Coronary angiography
has been the standard of comparison for determining the
initial success of angioplasty, and angiographic variables
have been shown to have prognostic value (1,2). Because
the angiographic appearance of the dilated vessel may not
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stenosis. UsingCox Hazards model regression of survival
without events, the number of transient qualitative thal-
lium defects also predicted clinical events and restenosis.
At I year after angioplasty, 24% of patients with these
variables had restenosis compared with only 6% of those
without these variables and 36% of patients with these
variables had a clinical or treatment event compared
with 8% of patients without these variables. Three mea-
sures of the adequacy of myocardial perfusion (post-
angioplasty gradient, reduced thallium clearance and
transient thallium defects) were additive predictors of
adverse events after coronary angioplasty with the rel-
ative risk being approximately four times greater in pa-
tients with these variables than in those without. Such
adverse events, therefore, are usually a consequence of
inadequate revascularization.
(J Am Coil CardioI1987;LO:275-83)
reflect the physiologic impact of a residual stenosis on myo-
cardial perfusion, other potential methods of assessing the
patient may be superior. These include the residual coronary
pressure gradient measured at the end of the procedure and
the relative myocardial perfusion assessed by thallium-20 I
imaging. The gradient is readily available, but its accuracy
is uncertain. Alternatively, the additional benefit of the thal-
lium study in this setting is also uncertain, although its
prognostic value early after myocardial infarction or in med-
ically treated coronary artery disease has been demonstrated
(3-6).
We have previously demonstrated (2) improved detection
of the severity and distribution of regional myocardial per-
fusion defects after coronary angioplasty using computer-
assisted quantitative analysis compared with qualitative as-
sessment of the thallium images. Accordingly, the purpose
of the present study was to compare clinical, exercise and
computer-assisted analysis of early postangioplasty exercise
thallium images with catheterization variables obtained at
the time of angioplasty for their independent prognostic
0735-1097/87/$3.50
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value after angiographically successful coronary angio-
plasty.
Methods
Study patients. The patient group consisted of 50 Na-
tional Heart, Lung, and Blood Institute PTCA registry pa-
tients (35 male and 15 female; mean age 51 ± 10 years)
from a group of 67 consecutive patients who had undergone
single vessel coronary angioplasty to the left anterior de-
scending (n = 46), right (n = 3) or left circumflex (n =
I) coronary artery for severe stable angina. Seventeen of
the 67 patients were excluded because of either inadequate
follow-up, failed angioplasty or the lack of pre- and post-
angioplasty thallium exercise imaging. The study population
was followed according to National Heart, Lung, and Blood
Institute protocol guidelines for a mean of 18 months (range
I to 49) after coronary angioplasty. Successful angioplasty
was defined as I) any reduction in pressure gradient across
the stenosis measured during pullback of the dilating cath-
eter, and 2) angiographically documented >20% reduction
in luminal narrowing at the site of the original stenosis. All
patients were considered appropriate candidates for coronary
artery bypass surgery and none had had a previous operation.
Eleven patients had sustained a previous myocardial in-
farction. Immediately after successful angioplasty, beta-re-
ceptor blocking agents were discontinued but long-acting
nitrates or calcium channel blockers, or both, were contin-
ued with aspirin for 6 months. Heparin was used for 12
hours after the procedure. These agents were discontinued
at the discretion of the treating cardiologist in some cases.
Exercise thallium-201 myocardial image acquisition.
Exercise testing was performed within I week before coro-
nary angioplasty and repeated after angioplasty, in most
cases within 2 weeks (mean 2.1 ± 1.5), using a previously
reported protocol (2,7 to 10). Symptom-limited treadmill
exercise was performed using a Bruce protocol until the
appearance of angina, markedly abnormal ST segment changes
or ventricular arrhythmias on the 12 lead electrocardiogram
(ECG) or generalized fatigue. Initial postexercise thallium
images were collected within 5 minutes after stopping ex-
ercise. Intermediate and delayed images were collected ap-
proximately 30 and 180 minutes, respectively, after the
initial injection of thallium-20 I. Imaging was performed for
8 minute acquisitions in the anterior and 500 and 70° left
anterior oblique projections.
Qualitative interpretation of thallium-201 images.
Images were interpreted qualitatively by three experienced
observers. For this purpose, the left ventricle was divided
into three segments in each projection. Thallium-201 activ-
ity in each zone was graded qualitatively on a 5 point scale
from a = absent activity to I = definitely reduced but not
absent and 2 = normal with half grades permitted, as pre-
viously reported (1,3).
Quantitative interpretation of thallium-201 images.
Thallium-201 images were also analyzed using a previously
reported computer-assisted method (2,8). Briefly, an op-
erator-determined ellipse was fitted around the left ventric-
ular activity of the intermediate image followed by auto-
matic realignment of the initial and delayed images (to fit
within the same ellipse) and weighted background subtrac-
tion. Thallium-201 activity profile curves from the three
serial myocardial images were derived and normalized to
the hottest nine point smoothed pixel within the ellipse of
the initial postexercise myocardial image. The left ventric-
ular activity was subdivided into five segments of equal
length along the perimeter. Basal segments I and 5 from
each view were excluded from the analysis of postangio-
plasty prognostic variables because of their relatively high
observer variability and the fact that exclusion of these seg-
ments improved specificity without affecting sensitivity (8).
This left three segments/view or a total of nine segments.
Mean normalized segmented thallium-201 activity was then
determined. The difference between delayed and initial thal-
lium-20l activity in each segment represented the amount
of regional thallium redistribution between initial and de-
layed images. Thallium clearance rate in each segment was
also quantified and expressed as half-time (t,/,) in hours, by
fitting a monoexponential curve to the initial, intermediate
and delayed regional activity.
Angiographic evaluation of the severity of coronary
artery stenosis. The severity of a coronary artery stenosis
was expressed as a percent of the pre- and poststenotic
luminal diameter (II). The narrowest portion of the vessel
lumen at the site of stenosis and the normal luminal diameter
proximal and distal to the stenosis were measured in at least
three oblique views in the coronary angiograms obtained
before and after coronary angioplasty. Pressure gradients
Table 1. Summary of Adverse Events After Percutaneous
Transluminal Coronary Angioplasty in 50 Patients
Event Interval
No. (%) (mo ± SO)
Treatment events
Repeat PTCA 10 (20) 5.2 ± 3.8
Coronary artery bypass I (2)
grafting
New drug therapy* 9 (18) 8.1 ± 7.7
Clinical events
Stable angina II (22) 5.3 ± 7.3
Unstable angina 5 (10)
Myocardial infarction I (2) 31.0
Newly ( +) exercise TI-20 I* [4 (28) 8.7 ± 9.1
Restenosis
>30% Increase in luminal 15 (30) 5.9 ± 3.6
diameter reduction
*Not classified as adverse events in the subsequent statistical analysis.
PTCA = percutaneous transluminal coronary angioplasty; TI-201 = thal-
lium-201.
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across the stenosis were measured before and after inflation
of the balloon at the stenotic site. At 6 months after the
initial procedure, or when clinical indications arose earlier.
38 patients underwent repeat coronary angioplasty.
Adverse events during follow-up (Table 1). Because
there were no deaths during the follow-up period. adverse
events were categorized as treatment. clinical or restenosis.
Treatment events were defined as repeat coronary angio-
plasty, coronary artery bypass surgery and reinstitution of
beta-blocker therapy or introduction of new calcium channel
blocker therapy. Only repeat coronary angioplasty and by-
pass surgery were considered in the subsequent analysis of
prognostic variables and survival without treatment events.
Clinicalevents were definedas the recurrenceof either stable
or unstable angina, myocardial infarction and the presence
of a newly positive exercise test. Only the recurrence of
angina and myocardial infarction were considered in the
subsequent statistical analysis. Restenosis was defined as a
>30% absolute increase in luminal diameter narrowing at
repeat catheterization (that is. 20 to 50% narrowing).
Statistical analysis. Stepwise logistic regression anal-
ysis was performed using the BMDP Statistical Software
program BMDPLR (Health Services Computing Facility.
University of California. Los Angeles) on clinical. angio-
graphic. exercise and scintigraphic variables. This analysis
was performed to identify the variables that correlated with
the presence or absence of adverse events and was used to
determine the strength of each patient variable for predicting
future events. Univariate analysis was performed initially:
then the variables were entered or removed in a stepwise
manner to identify those that best fit the logistic model. A
correlation matrix of coefficients determined whether sig-
nificant variables were positively or negatively correlated
with adverse events. After each variable was ranked by its
chi-square value. it was entered into the logistic regression
model in decreasing order of the chi-square value with step-
wise reevaluation of the probability chi-square value. The
stepwise logistic regression analysis continued in this fash-
ion until no variable improved the significance of the chi-
square value. Using this model, a variable may have prog-
nostic value if considered alone, but may not achieve sig-
nificance when evaluated with other covariables because it
yields no additional predictive power to the superior patient
variables. A probability (p) value <0.05 was considered
significant.
Cox regression analysis with incomplete survival data
was also performed (BMDP program BMDP2L) to deter-
mine which postangioplasty variables were selected when
the complication-free interval before the occurrence of the
adverse events was considered. This analysis starts with a
stepwise logistic regression analysis but also considers the
time before complications occur. Regression covariates were
chosen from the significantvariablesderived by the stepwise
logistic regression analysis. The duration of follow-up until
adverse events was then incorporated into the regression.
Although this model is usually employed to determine sur-
vival, as in life-table analysis, it can be modified to examine
survival without complications; for example, restenosis, re-
Table 2. Summary of Adverse Events After Percutaneous Transluminal Coronary Angioplasty in t8 Patients
Patient Age (yr) Treatment Clinical Restenosis Medication Late TI-201
No. &Sex Event Event Ilk (increaser] Restarted Study
1 47 M SA (4) 50 (2) , (4)
2 51 F PTCA (6) SA (6) ~5 (7) • (6)
3 44 M SA (2) 60 (7) "(7) • (2)
4 40 M PTCA (I) SA (I) 60(2) , (17)
5 51 M 40 (12) (6)
6 64 M UA (9) lOt (9) Not done
7 62 M PTCA (6) LJA (2) 65 (3) , (3) , (6)
8 39 F PTCA (6) SA (3) 60 (6)
9 62 M PTCA (4) LJA (2) 65 (4) (2) , (4)
10 53 F PTCA (3) SA (I) 70 (3) • (3)
II 45 M PTCA (I) SA (I) 79 (I) Not done
12 62 M SA (12) 40 (12) Not done
13 54 F PTCA (8) SA (5) 85* (6) • (6)
14 45 M IMI (31) • (24) • (32)
15 52 M PTCA (6) SA (2) 85 (6) , (6)
16 59 F SA (7) • (10)
17 53 F CABG (3) LJA (2) 55 (3) (3) Not done
18 50 M LJA (2) 45 (6)
Mean 53 ± 9 II (5 ± 4) 17 (5 ± 7) 60 ± 16 (6 ± 4) 7 (X ± 8) 10 (9 ± 9)
*New proximal left anterior descending artery stenosis; previous 10% midvessel stenosis after angioplasty. ' = Not considered as a restenosis.
Values in parentheses are times in months after percutaneous trans luminal coronary angioplasty to event. CABG = coronary artery bypass grafting; IMI
= inferior myocardial infarction; SA = stable angina; UA = unstable angina; other abbreviations as in Table I.
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peat coronary angioplasty, coronary bypass surgery, recur-
rent angina, myocardial infarction and death.
Results
Description of adverse events. Eighteen (38%) of the
50 patients who underwent coronary angioplasty had an
adverse event during the follow-up period (Table 2). Ten
(20%) of the 18 patients had both a treatment and a clinical
event. There were 10 treatment events during follow-up ;
nine patients had repeat left anterior descending coronary
angioplasty and one patient underwent single left anterior
descending coronary artery bypass grafting after unsuc-
cessful repeat angioplasty.
Adverse clinical events occurred in 17 patients during
follow-up. Eleven patients had recurrent stable angina, 5
had unstable angina and I patient had an inferior myocardial
infarction 31 months after coronary angioplasty as a result
of a new lesion in the proximal right coronary artery.
Forty-one repeat catheterizations were perf ormed ill 38
patients , either at the routine 6 month interval or for clinical
indications on readmission. Fifteen (39%) of these patients
had restenosis, generally at the site of the originally dilated
lesion. However, one patient developed a new left anterior
descending coronary artery stenosis proximal to the initial
dilation that required angioplasty, and another patient had
an inferior wall myocardial infarction as a result of a new
right coronary artery occlusion. The mean luminal reduction
in patients classified as having a restenosis was 87 ± 11 %
(an average increment of 60 ± 16%). The average luminal
reduction in patientsundergoing repeat coronary angioplasty
was 89%, an increase of 64% over the postangioplasty le-
sion. By comparison, recatheterized patientsnot undergoing
repeat angioplasty had an average 33% stenosis, a mean
increase of only 6% from the postangioplasty study. No new
stenoses > 50% luminaldiameter were noted in the coronary
vessels not subject to angioplasty in patients withan adverse
event.
Stepwise logistic regression analysis. The univariate
correlates of adverse events are summarized in Table 3. The
results of the stepwise logistic regression of clinical, ex-
ercise, angiographic and scintigraphic patient variables are
presented in Table 4. A postangioplasty gradient of > 20
mm Hg best predicted the presence of either a clinical or a
treatment event (p < 0.(03) and the number of segments
with delayed thallium-201 clearance on the postangioplasty
exercise images best predicted the presence of a clinical or
treatment event (p < 0.003) and restenosis (p < 0.0003).
Age, sex, maximal exercise heart rate, maximal exercise-
induced ST segment depression, prior myocardial infarc-
tion, postangioplastystenosis and fixed thallium-20 I defects
(qualitative and quantitative)on the postangioplasty images
did not add to the value of the gradient or the clearance in
predicting later adverseevents. The stepwiselogisticregres-
sion probability (p) equation for calculating the risk of ad-
verse events can be derived using the regression coefficients
in Table 4. Forexample, the risk of restenosis after coronary
angioplasty is given below:
e I I .Y6 + O.75t1!rad icn ll I O.561c1ea ranccl J
P == I + e I 1.96 + O.751~rad icnll + 0.56(dcarancCII '
where - 1.96 = the stepwise logistic regression constant.
(gradient) = the postangioplasty gradient. where a gradient
> 20 mm Hg = I and a gradient :520 mm Hg = 0 and
(clearance) = the number of segments with delayed thal-
lium-20I clearance. Similar equations, not shown here. were
generated for clinical events. treatment events and clinical
or treatment events. From these probability equations, curves
depicting the risk of each adverse event were plotted and
are illustrated in Figure I . Using these curves. the proba-
bility of each adverse event can be determined for various
combinations of the significant predictors derived by the
stepwise logistic regression analysis.
Cox regression of survival data. The significant prog-
nostic variables derived using the Cox hazards function are
summarized in Table 5. Once again. the postangioplasty
gradient was predictive of clinical events, treatment events
(p < 0.03) and restenosis. Thallium-201 clearance was also
predictive of restenosis. The number of qualitatively deter-
mined reversible thallium-20I defects was also predictive
of clinical events and of restenosis. The remaining covar-
Table 3. Univariate Correlates of Adverse Events
Chi-Square p Value
Treatment events
Post-PTCA gradient 7.0 0.01
Sex (male/female) 6.8 0.01
Thallium clearance 2.8 0.09
History of MI 1.2 0.29
Peak exercise heart rate 0.7 0.40
Clinical events
Post-PTCA gradient 4.7 0.04
History of MI 4.0 0.06
Thallium clearance 3.4 0.08
Sex (male/female) 1.8 0.20
Peak exercise heart rate 1.1 0.29
Restenosis
Post-PTCA gradient 6.8 0.01
Sex (male/female) 5.3 0.03
Thallium clearance 4.6 0.04
History of MI 3.1 0.09
Clinical or treatment event
Post-PTCA gradient 6.9 0.()(J9
Thallium clearance 2.2 0. 14
Transient defects 2.1 0.15
History of MI 0.8 0.38
Peak exercise heart rate 0.2 0.66
MI = myocardial infarction ; PTCA = percutaneous transluminal coro-
nary angioplasty.
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Treatment events
Post-PTCA gradient
Thallium-20 I clearance
Constant
Clinical events
Thallium-201 clearance
Post-PTCA gradient
Constant
Restenosis
Thallium-20 I clearance
Post-PTCA gradient
Constant
Clinical or treatment event
Thallium-20 I clearance
Post-PTCA gradient
Constant
Abbreviations as in Table I.
Regression
Coefficient
0.77
0.24
~U2
0.45
D.68
-1.27
D.56
D.75
- 1.96
0.76
0.43
-133
Chi- P
Square Value
4.1 0.04
3.7 0.05
9.6 0.002
3.6 0.06
13.2 0.0003
33 0.07
8.6 0.003
4.7 0.03
iables analyzed were not significant prognosticators for post-
angioplasty adverse events using the Cox regression model.
The "survival" curves for patients with and without the
preceding significant prognostic variables are shown in Fig-
ure 2 for survival without restenosis, clinical events, treat-
ment events and clinical or treatment events, respectively.
Survival without restenosis was 80 and 76% at 6 and 12
months, respectively, when the postangioplasty gradient was
2:20 mm Hg and slow thallium clearance and a qualitative
ischemic defect were present, compared with 96 and 94%.
respectively, when these variables were absent. Survival
without a clinical or treatment event was 70. 64 and 52%
when the significant variables were present. as compared
with 94, 92 and 88% when they were absent at 6, 12 and
24 months, respectively. Thus, using the Cox model, at I
year after successful coronary angioplasty, 24% of patients
with these variables had restenosis of their original coronary
dilation site compared with only 6% of patients without
these significant variables. At I year, 36% of patients with
these variables had experienced a clinical or treatment event
compared with only 8% of patients without. The risk of
restenosis, and a clinical or treatment event is approximately
four times greater in patients in whom these significant
independent predictors are present than in those without
them. The risk of adverse events when one or more of these
predictors is present is intermediate.
The Cox hazards function shown later can be used to
calculate the survival using the regression coefficients shown
in Table 5. For example, survival without restenosis in this
postangioplasty population is:
H(t.z) :::::: Ho(t)e 1.2(gradientl ! O.27(reversiblel + O.15(clearanCl'I.
where t = time of observation, z = the vector of covariate
observations, (gradient) = the postangioplasty gradient where
>20 mm Hg = I and ::;20 mm Hg = 0 (reversible)
number of qualitative reversible defects and (clearance)
number of segments with slow thallium-20l clearance.
Discussion
Restenosis is an important occurrence in the first year
after percutaneous transluminal coronary angioplasty and.
therefore, early predictors of restenosis would be valuable.
The present study of patients with single vessel angioplasty.
primarily of the left anterior descending coronary artery.
demonstrates that the postangioplasty pressure gradient has
prognostic value for predicting subsequent adverse events;
the postangioplasty angiographic percent stenosis does not
correlate. Furthermore, there is a better correlation when
the postangioplasty gradient is combined with thallium scan
variables. Both are measures of flow impairment and this
suggests that such adverse events are a result of inadequate
revascularization. It is uncertain why measuring both is
better than measuring one. One reason may be limitations
in the accuracy of both techniques, especially the gradient
measurement.
Comparison with other angioplasty studies. The length
of follow-up and adverse event rates in our study population
were similar to previously reported data from the complete
National Heart, Lung, and Blood Institute PTCA registry
(12). This registry reported that 72% of patients with a
successful dilation remained improved at I year. after which
67% remained asymptomatic. In our study group. 60% were
asymptomatic at I year and 52% were still in improved
condition after 2 years. The rates of treatment events were
similar in the two populations, with our study group having
slightly more repeat coronary angioplasty (20 versus 14%)
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Figure l. This series of curves illustrates the calculated stepwise
logistic regression probabilities of adverse events for patients with
o to 15 myocardial segments with abnormally slow thallium-20I
(TI-201) clearance determined by computer after assisted quanti-
tation. The upper curve (e) describes the probability of an ad-
verseevent in postangioplasty(PTCA) patients with a transstenotic
pullback gradient >20 mm Hg; the lower curve (0) describes
patients with a gradient ::;20 nun Hg, The probabilitiesof a treat-
ment event (A), clinical events (B), restenosis (C) and either a
treatment or clinical event (D) are presented.
and fewer coronary artery bypass graft procedures (4 versus
14%).
Restenosis in the entire National Heart, Lung, and Blood
Institute PTCA registry ranged between 25 and 36% from
center to center during the first year of follow-up. Our study
group of 50 patients had a total of 60 coronary angioplasty
procedures, 10of which were repeat dilations of restenosed
vessels. Thirty-eight patients (76%) had repeat catheteriza-
tion, a lower rate than that in the total registry. The majority
of these studies were done for clinical reasons. Fifteen (39%)
of the 38 patients had restenosis after their initial dilation
procedure. If patients who were not studied because of their
stable clinical course had been included, we anticipate that
the rate of restenosis would have decreased into the range
reported by the National Heart, Lung, and Blood Institute
registry. Thus, in terms of clinical events. treatment events
l ACC Vol. 10, No.2
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Treatment events
Post-PTCA gradient
Clinical events
Transient defects
Post-PTCA gradient
Restenosis
Post-PTCA gradient
Transient defects
Delayed thallium-20 I clearance
Clinical or treatment event
Transient defects
Post-PTCA gradient
Abbreviations as in Table I.
Regression
Coefficient
1.26
0 .29
1.31
1.22
o.n
0. 15
0.29
1.31
Chi- P
Square Value
2.9 0.09
9. 1 0.0 1
4.8 o.m
19.0 0.000 1
13.7 0.00 1
74 0.006
9.1 0.0 1
4.8 o.m
and restenosis, our study group was comparable with the
population of patients undergoing coronary angioplasty dur-
ing this time period.
Several studies (7. /3 to /5) have demonstrated improve-
ment in exercise and ECG thallium scintigraphic abnor-
malities af ter successful coron ary angioplasty, In 66 pa-
tients from the National Heart. Lung, and Blood Institute
registry (13) with complete paired (pre- and postangioplasty)
data from studies of myocardial functional capacity, only
7% developed an ECG and symptom-positive exercise test
during 8 months of follow-up. No qualitatively abnormal
thallium studies were observed. Seven of eight patients who
became symptomatic after coronary angioplasty had con-
version of their negative early postangioplasty exercise thal-
lium test to positive when symptoms later reappeared, Two
asymptomatic patients in this group developed restenosis
and both had an abnormal exercise thallium study at the
time of recatheterization at 6 months. No attempt was made
to usc the initial postangioplasty test results to predict sub-
sequent adverse events.
In another study ( / 5) using quantitat ive analysis of the
thalliu m images. 13 patients before and after successful
coronary angioplasty had no change in thallium-201 wash-
out but a significant increase in " vitality index" and de-
crease in redistribution after successful angioplasty. This
study also did not analyze whether the results of computer-
quantitated thallium scintigraphy were predictive of later
adverse events.
In an attempt to evaluate the prognostic value of early
(2 10 12 weeks) postangioplasty exercise thallium scintig-
raphy . Wijns et al. (5) followed up 57 patients after suc-
cessful coronary dilation. Only 4 ( 15%) of 26 patients with
a negative thallium study developed restenosis, whereas 24
(77%) of 31 patients with a positive study had restenosis.
Angina reappeared in 61% of patients with a positive thal-
lium test compared with only 19% of those with a negative
thallium test. Thus, a positive thallium study had a high
predictive value for later restenosis and recurrent angina.
The prognostic significance of the postangiography gradient
remains uncertain (16).
The clinical correlates of restenosis after coronary an-
gioplasty have been examined at the National Heart, Lung.
and Blood Institute and at Emory University (17-19). Sev-
eral variables including male gender, angioplasty of bypass
graft stenosis. preangioplasty severity of angina, absence
of previous myocardial infarction and left anterior descend-
ing disease were selected as being significantly correlated
with a repeat angioplasty procedure. The majority of the
patients we studied were male and all repeat coronary an-
gioplasty procedures were performed on the left anterior
descending coronary artery. Therefore, our data could not
analyze the influence of these variables. There was a trend
toward the occurrence of postangioplasty clinical events in
patients with a prior history of myocardial infarction, but
none of the other clinical and exercise variables analyzed
achieved statistical significance in the Cox or logistic regres-
sion models.
Value of stenosis gradient and thallium scan mea-
surements. This study confirms and extends the preceding
observations. By performing stepwise logistic regression
analysis on clinical, exercise, catheterization and scinti-
graphic variables, it has been demonstrated that clinical and
treatment events can be predicted by a postangioplasty gra-
dient > 20 mm Hg and delayed thallium-201 clearance, and
that the number of segments with delayed thallium-20 I
clearance also is predictive of restenosis. When a Cox
regression of survival data was added to the stepwise logistic
regression data, here indicating survival without adverse
events, similar variables were included and the number of
transient qualitative thallium-20 I defects on the postangi-
opJasty images was also found to be predictive of subsequent
clinical events and restenosis. At I year after successful
coronary angioplasty, the risk of clinical and treatment events
and restenosis was four times higher in patients with these
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Figure 2. This figure illustrates the " survival" curves derived by Cox analysis for patients with all (lowe r curv e) or none (upper curve) of the
significant prognostic variables present. The upper curve in each figure represents the survival of postangio plasty patients without any of the significant
prognostic variables present. The lower curve describes the survival without adverse eve nts of patients with all variables present. Postangioplasty
patients with adverse prognostic variables had a significantly greater (p < 0 .01) risk of a treatment event (A), clinica l event (B), restenosis (C) and a
clinical or treatment event (D), than did patients without these variables . The risk of adverse events in patients with only one or two of the prognostic
variables was intermediate .
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adverse prognostic variables. Although these variables were
statistically independent in the regression analysis, the cor-
relation found between catheterization and imaging vari-
ables would appear to be more than coincidental.
Implications. The fact that these variables predicted fu-
ture cardiac events implies that a subtle residual impairment
in myocardial perfusion is already present early after suc-
cessful coronary angioplasty in patients at risk of later ad-
verse events. This triad of abnormalities predictive of sub-
sequent adverse events (postangioplasty gradient > 20 mm
Hg, delayed thallium-20 I clearance and transient qualitative
thallium-20 I defects) reflects a limitation of coronary blood
flow. Therefore, adverse events are mostly explained by
progression of residual functional abnormalities and not by
random progression of coronary artery disease. These find-
ings are consistent with other studies that suggest that be-
yond 6 months after coronary angioplasty, the occurrence
of adverse clinical events is rare and often the result of
progression of disease unrelated to the initial coronary di-
lation procedure, These results pertain to angioplasty of the
left anterior descending coronary artery and may not apply
to multi vessel angioplasty or dilation of other major arteries.
On the basis of the results of this study we recommend
that patients undergo an early postangioplasty exercise thal-
lium test that, if positive, should prompt consideration of
repeat catheterization to detect restenosis, especially if re-
current angina pectoris occurs.
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